Loading asset research
Unicycive Therapeutics Inc. Common Stock
UNCYNasdaq · USD · StocksQuote as of · Exchange session not verified$5.29
-0.38%
Today
UNCY
Loading 1D prices…
Market cap
$144.9M
Volume
1.1M
52w high
$8.7452w low
$3.71Company profile
Unicycive Therapeutics Inc. Common Stock
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I clinical trial for the treatment of acute kidney injury and pre-clinical stage for the treatment of chronic kidney disease. The company was incorporated in 2016 and is headquartered in Mountain View, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Mountain View, CA, United States
Employees
21
Fiscal year end
1231
CIK
1766140
Session & valuation
Open$5.34
Previous close$5.31
Day high$5.40
Day low$5.22
30-day avg. volume749K
Outstanding shares27.9M
Diluted EPS-$1.67
Latest annual period
P/E (trailing)-3.17
P/E (forward)3.18
Price / book2.77
Beta1.78
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| NRXPNRX Pharmaceuticals Inc. Common Stock | $147.2M | $1.2M | -2336.49% | -$1.34 | +0.15% | Hold |
| MENSJyong Biotech Ltd. Ordinary Shares | $151.3M | $0.00 | — | -$0.06 | -1.00% | Unrated |
| OGIOrganigram Global Inc. Common Shares | $151.4M | — | — | -$0.194 | -1.87% | Buy |
| ADCTADC Therapeutics SA Common Shares | $136.6M | $81.4M | -175.28% | -$1.12 | -4.50% | Buy |
| SPRBSpruce Biosciences Inc. Common Stock | $154.3M | $0.00 | — | -$50.83 | -1.20% | Buy |